The first stem cell trial

The FDA has approved Geron's stem cell trial, the first human therapeutic trial utilizing embryonic stem cells. This first trial is to determine the viability of treating spinal cord injuries. The treatment is currently termed GRNOPC1.

 

Update: the trial was halted in 2011 after enrolling only 4 patients due to cost concerns.

Psilocybin to treat cancer anxiety

Building on previous studies, a recent study discussed in Nature showed that psilocybin, the active psychedelic chemical in "magic" mushrooms, may be beneficial for treating the anxiety and depression accompanying chronic diseases such as cancer. These positive effects could last for a year or more.

Johns Hopkins is recruiting volunteers for a new study on psilocybin and cancer. It is a registered clinical trial.